OTTAWA, Feb. 15, 2019 /CNW/ - The food recall warning issued on February 14, 2019 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.
Trade Technocrats Ltd. is recalling Brewer's Debittered Yeast from the marketplace because it contains peanut which is not declared on the label. People with an allergy to peanut should not consume the recalled products described below.
The following products have been sold in Ontario, Manitoba, Quebec and Saskatchewan.
Recalled products
Brand
Product
Size
UPC
Codes
None (packaged by: Trade Technocrats Ltd.)
Brewer's Debittered Yeast
454 g
7 72696 00026 7
All codes sold between June 6, 2018 and February 15, 2019, inclusive
None (packaged by: Trade Technocrats Ltd.)
Brewer's Debittered Yeast
114 g
7 72696 00027 4
All codes sold between June 6, 2018 and February 15, 2019, inclusive
What you should do
Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.
If you have an allergy to peanut do not consume the recalled products as they may cause a serious or life-threatening reaction.
This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.
The CFIA is verifying that industry is removing recalled products from the marketplace.
Reactions
There have been no reported reactions for the Trade Technocrats Ltd. Brewer's Debittered Yeast. However, there have been reported reactions associated with other recently recalled Brewer's Yeast products.
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....